Amphenol Corporation

New York Stock Exchange
Bullish +65

Amphenol Corporation $APH Shares Acquired by Fjarde AP Fonden Fourth ...

πŸ“ˆ Fjarde AP Fonden increased its Amphenol stake by 51.8% in Q1 2026, holding 664,039 shares valued at $83.9 million.

πŸ“Š Other institutional investors like Brighton Jones LLC and NewEdge Advisors significantly raised their holdings in the fourth and second quarters respectively.

πŸ’° Amphenol reported Q1 EPS of $1.06, beating analyst estimates by $0.11 on revenue of $7.62 billion.

πŸš€ Revenue surged 58.4% year-over-year compared to the same quarter in the prior year.

πŸ“‰ The company achieved a net margin of 17.24% and a return on equity of 37.44% for the quarter.

🎯 Analysts have raised price targets, with BNP Paribas Exane increasing its target to $200.00 and UBS setting it at $178.00.

πŸ“ The consensus analyst rating is 'Moderate Buy' with an average price target of $178.07.

πŸ’΅ Amphenol declared a quarterly dividend of $0.25 per share, yielding 0.6% annually.

πŸ“… Q2 2026 earnings guidance is set between $1.140 and $1.160 EPS.

πŸ‘” CEO Richard Adam Norwitt sold 17,500 shares in May for a total value of $2.5 million.

πŸ“‰ Insiders have sold 130,775 shares valued at $18.7 million over the last ninety days.

🏒 Institutional investors and hedge funds collectively own 97.01% of the company's outstanding stock.

Bullish Signals
  • Amphenol beat Q1 earnings estimates with EPS of $1.06 versus a consensus of $0.95, demonstrating strong operational performance.
  • Revenue grew significantly by 58.4% year-over-year to reach $7.62 billion, indicating robust demand across its product portfolio.
  • The company maintains healthy profitability metrics with a net margin of 17.24% and a return on equity of 37.44%.
  • Major analysts including BNP Paribas Exane, UBS Group, JPMorgan Chase, and Rothschild & Co have recently raised price targets or reaffirmed buy ratings.
  • The stock has a consensus price target of $178.07, which is above the recent trading price of $164.40.
  • Amphenol provided positive Q2 2026 guidance with EPS expectations between $1.140 and $1.160.
  • The company has a strong balance sheet indicated by a quick ratio of 1.26 and a current ratio of 1.71.
Risk Factors
  • CEO Richard Adam Norwitt sold 17,500 shares in May for $2.5 million, representing a slight reduction in his direct ownership stake.
  • Insiders have collectively sold 130,775 shares valued at $18.7 million over the last ninety days, totaling 1.42% of the stock.
Full Analysis
Amphenol Corporation (NYSE: APH) saw significant institutional activity in the first quarter of 2026, with Fjarde AP Fonden increasing its stake by 51.8% to own approximately $83.9 million worth of shares. Other notable investors including Brighton Jones LLC, Revolve Wealth Partners, and NewEdge Advisors also boosted their positions during the fourth or second quarters, reflecting continued institutional interest in the electronics manufacturer. Analyst sentiment remains strongly positive following a recent earnings beat where Amphenol reported $1.06 EPS against a consensus of $0.95 and revenue of $7.62 billion, up 58.4% year-over-year. Major financial institutions including BNP Paribas Exane, UBS Group, JPMorgan Chase, and Rothschild & Co have recently raised their price targets or reaffirmed buy ratings, with a consensus target price of $178.07. The company reported strong financial health with a net margin of 17.24% and a return on equity of 37.44%. It has set Q2 2026 guidance between $1.140 and $1.160 EPS, while maintaining a quarterly dividend of $0.25 per share payable on July 15th to investors of record by June 23rd. Despite the bullish analyst consensus and strong earnings growth, CEO Richard Adam Norwitt sold 17,500 shares in May for approximately $2.5 million, reducing his direct ownership slightly. Insiders have collectively sold over $18.7 million worth of stock in the last ninety days, though they still retain 1.42% of the company's total shares.